Loss of skeletal muscle during systemic chemotherapy is prognostic of poor survival in patients with foregut cancer

BACKGROUND: Malnutrition, weight loss, and muscle wasting are common in patients with foregut cancers (oesophagus, stomach, pancreas, liver, and bile ducts) and are associated with adverse clinical outcomes. However, little is known about the changes in body composition that occur in these patients...

Descripción completa

Detalles Bibliográficos
Autores principales: Daly, Louise E., Ní Bhuachalla, Éadaoin B., Power, Derek G., Cushen, Samantha J., James, Karl, Ryan, Aoife M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2018
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5879982/
https://www.ncbi.nlm.nih.gov/pubmed/29318756
http://dx.doi.org/10.1002/jcsm.12267

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5879982/
https://www.ncbi.nlm.nih.gov/pubmed/29318756
http://dx.doi.org/10.1002/jcsm.12267

Ejemplares similares